Substrate
financeSourced

Virtuix Holdings Enters Material Definitive Agreement

Virtuix Holdings Inc. disclosed entry into a material definitive agreement on June 2, 2026. The pact triggers immediate contractual obligations and requires the company to furnish related financial exhibits to regulators within standard SEC deadlines.

SEC EDGAR — Virtuix Holdings Inc. (VTIX)
1 source·Jun 1, 8:00 PM·1m read
Virtuix Holdings Enters Material Definitive Agreementbenzinga.com
Audio version
Tap play to generate a narrated version.

Virtuix Holdings Inc. (VTIX) filed an 8-K on June 2, 2026 reporting entry into a material definitive agreement under Item 1.01, along with Regulation FD disclosure under Item 7.01 and related exhibits under Item 9.01.

The filing affects Virtuix Holdings Inc., its shareholders, and the counterparty to the agreement. The 8-K does not disclose the counterparty name, contract type, or dollar size. Virtuix is a publicly traded company with CIK 0001606242 that has been subject to standard SEC periodic reporting requirements since its registration.

The operational change consists of the company moving from a state with no such agreement in force to one bound by the new material contract. The agreement took legal effect on or before the June 2, 2026 filing date. The company must now perform its obligations under the contract and maintain compliance with any covenants or milestones specified in the agreement.

Downstream consequences include the immediate activation of any notice, payment, or performance deadlines contained in the contract. Virtuix must incorporate the financial impact of the agreement into its next required quarterly or annual report. If the agreement involves issuance of securities, a separate registration statement or resale filing may become due.

Counterparties and auditors will require updated documentation to reflect the new arrangement in their own records and financial statements.

This marks the latest 8-K filing by Virtuix Holdings Inc. detailing a material definitive agreement. The company has used Form 8-K in the past to report similar corporate actions as required under SEC rules for events deemed important to investors. The filing includes exhibits that provide the full text or summary of the agreement for public inspection.

Coverage spread

Substrate’s article above is written from the primary record. Below: how mainstream outlets reported the same event.

No mainstream coverage of this story has surfaced yet.

Transparency

Confidence90%

Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.

Related Stories

U.S. Strikes Botswana-Flagged Tanker in International Waters; Iran Blockade in Effectthehindu.com
finance43 min ago

U.S. Strikes Botswana-Flagged Tanker in International Waters; Iran Blockade in Effect

A U.S. aircraft fired an AGM-114 Hellfire missile into the engine room of the M/T Lexie on Tuesday, disabling the unladen vessel as it headed toward Kharg Island. The strike followed repeated ignored warnings over 24 hours.

FI
FI
OS
BBC News
4 sources
Fed Chairman Names Two Outside Advisers During Transitionprnewswire.com
finance43 min ago

Fed Chairman Names Two Outside Advisers During Transition

Federal Reserve Chairman Kevin Warsh appointed two interim advisers shortly after taking the post. One previously contributed to a conservative plan calling for major changes at the central bank.

FI
Wall Street Journal
2 sources
Forte Biosciences Accepts Resignation of Director David Veitchinsidermonkey.com
finance2 hrs agoSourced

Forte Biosciences Accepts Resignation of Director David Veitch

Forte Biosciences disclosed the resignation of independent director David Veitch from its board effective June 1 2026. The departure reduces the company's board size and triggers standard SEC and Nasdaq disclosure obligations for director changes at the clinical-stage biopharmace…

SEC EDGAR — Forte Biosciences, Inc. (FBRX)
1 source